Among the 23 cancers within the TCGA ATAC-seq dataset, we found that the regions of accessible DNA which overlapped p52-activated ETS1 binding sites were highly enriched and specific to glioma patients (Fig. 1f). This evidence concerns the gene NFKB2 and cancer.